154 related articles for article (PubMed ID: 33206309)
21. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract][Full Text] [Related]
22. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis.
Fernández Montes A; López López C; Argilés Martínez G; Páez López D; López Muñoz AM; García Paredes B; Gutiérrez Abad D; Castañón López C; Jiménez Fonseca P; Gallego Plazas J; López Doldán MC; Martínez de Castro E; Sánchez Cánovas M; Tobeña Puyal M; Llorente Ayala B; Juez Martel I; López Flores M; Carmona-Bayonas A
Oncologist; 2019 Aug; 24(8):e687-e695. PubMed ID: 31147489
[TBL] [Abstract][Full Text] [Related]
25. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
Miyawaki E; Kenmotsu H; Mori K; Harada H; Mitsuya K; Mamesaya N; Kawamura T; Kobayashi H; Nakashima K; Omori S; Wakuda K; Ono A; Naito T; Murakami H; Endo M; Nakasu Y; Gon Y; Takahashi T
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):604-613. PubMed ID: 30851347
[TBL] [Abstract][Full Text] [Related]
26. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
[TBL] [Abstract][Full Text] [Related]
27. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
Zimmerman BS; Seidman D; Cascetta KP; Ru M; Moshier E; Tiersten A
Oncology; 2021; 99(5):280-291. PubMed ID: 33652435
[TBL] [Abstract][Full Text] [Related]
29. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
30. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J
BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
32. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
[TBL] [Abstract][Full Text] [Related]
33. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
[TBL] [Abstract][Full Text] [Related]
34. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
[TBL] [Abstract][Full Text] [Related]
35. Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis.
Hulsbergen AFC; Cho LD; Mammi M; Lamba N; Smith TR; Brastianos PK; Broekman MLD; Lin NU
Breast Cancer Res Treat; 2020 Feb; 180(1):147-155. PubMed ID: 31953697
[TBL] [Abstract][Full Text] [Related]
36. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
37. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
38. Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.
Merritt RE; Abdel-Rasoul M; Souza DM; Kneuertz PJ
J Surg Oncol; 2021 Mar; 123(4):881-890. PubMed ID: 33333590
[TBL] [Abstract][Full Text] [Related]
39. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
40. Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
Lee JH; Chen HY; Hsu FM; Chen JS; Liao WY; Shih JY; Yu CJ; Chen KY; Tsai TH; Yang JC
Oncologist; 2019 Dec; 24(12):e1417-e1425. PubMed ID: 31127020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
